Skip to Content
Press Releases
Close
Research reveals mechanisms behind “COVID toes”

Redness and swelling of the hands and toes, known as chilblain-like lesions, have been reported during the COVID-19 pandemic. A new study published in the British Journal of Dermatology uncovers the underlying mechanisms involved in such “COVID toes” symptoms. 

The study included 50 participants with COVID toes and 13 with similar chilblains lesions that arose before the pandemic. The mechanisms behind both types involved an immune response with high levels of certain autoantibodies as well as type I interferon, a key protein in the antiviral response.  

In addition to the immune system, endothelial cells that line blood vessels also appeared to play a critical role in the development of COVID toes and chilblains. 

“The epidemiology and clinical features of chilblain-like lesions have been extensively studied and published, however, little is known about the pathophysiology involved,” said senior author Charles Cassius, MD, of Hôpital Saint-Louis, in Paris, France. “Our study provides new insights.”

Additional Information

Link to Study: https://onlinelibrary.wiley.com/doi/10.1111/bjd.20707

About Journal

British Journal of Dermatology, BJD, is a top-ranked international dermatology journal, publishing the highest-quality research to advance the understanding and management of skin disease to improve patient outcomes. The journal publishes high impact global research, including that coming from the United States and Canada.

The British Journal of Dermatology is owned by the British Association of Dermatologists (BAD) the central association of practising UK dermatologists. Our aim is to continually improve the treatment and understanding of skin disease. For further information about the charity, visit www.bad.org.uk

About Wiley

Wiley is a global leader in research and education, unlocking human potential by enabling discovery, powering education, and shaping workforces. For over 200 years, Wiley has fueled the world’s knowledge ecosystem. Today, our high-impact content, platforms, and services help researchers, learners, institutions, and corporations achieve their goals in an ever-changing world. Visit us at  Wiley.com, like us on Facebook and follow us on Twitter and LinkedIn.

Back to top